|Part of a series on|
|Human growth and development|
|Development and psychology|
Ageing, also spelled aging, is the process of becoming older. In the narrow sense, the term refers to biological ageing of human beings, animals and other organisms. In the broader sense, ageing can refer to single cells within an organism which have ceased dividing (cellular senescence) or to the population of a species (population ageing).
In humans, ageing represents the accumulation of changes in a human being over time, encompassing physical, psychological, and social change. Reaction time, for example, may slow with age, while knowledge of world events and wisdom may expand. Ageing is among the greatest known risk factors for most human diseases: of the roughly 150,000 people who die each day across the globe, about two thirds die from age-related causes.
The causes of ageing are unknown; current theories are assigned to the damage concept, whereby the accumulation of damage (such as DNA breaks or oxidised bases) may cause biological systems to fail, or to the programmed ageing concept, whereby internal processes (such as DNA telomere shortening) may cause ageing.
The discovery, in 1934, that calorie restriction can extend lifespan twofold in rats, and the existence of animals that do show signs of aging, including mammals (negligible senescence phenomena) and potentially immortal animals such as Hydra, have motivated research into delaying and preventing ageing and thus age-related diseases.
- 1 Ageing versus immortality
- 2 Effects of ageing
- 3 Biological basis of ageing
- 4 Management and reversal
- 5 Society and culture
- 6 See also
- 7 References
- 8 External links
Ageing versus immortality
Human beings and members of other species, especially animals, necessarily experience ageing and mortality. In contrast, many species can be considered immortal: for example, bacteria fission to produce daughter cells, strawberry plants grow runners to produce clones of themselves, and animals in the genus Hydra have a regenerative ability with which they avoid dying of old age.
Even within humans and other mortal species, there are arguably cells with the potential for immortality: cancer cells which have lost the ability to die when maintained in cell culture such as the HeLa cell line, and specific stem cells such as germ cells (producing ova and spermatozoa). In artificial cloning, adult cells can be rejuvenated back to embryonic status and then used to grow a new tissue or animal without ageing. Normal human cells however die after about 50 cell divisions in laboratory culture (the Hayflick Limit, discovered by Leonard Hayflick in 1961).
After a period of near perfect renewal (in humans, between 20 and 35 years of age), ageing is characterised by the declining ability to respond to stress, increasing homeostatic imbalance and the increased risk of disease. This currently irreversible series of changes inevitably ends in death.
Effects of ageing
A number of characteristic ageing symptoms are experienced by a majority or by a significant proportion of humans during their lifetimes.
- Teenagers lose the young child's ability to hear high-frequency sounds above 20 kHz.
- A continuous decline in some cognitive processes occurs after a peak performance in the mid-20s age group.
- By age 30, wrinkles develop mainly due to photoageing, particularly affecting sun-exposed areas (face, hands) of fair-skinned individuals.
- Around age 35, female fertility declines sharply.
- In the mid-forties, presbyopia generally becomes apparent.
- Around age 50, hair turns grey in Caucasoids. Many men are affected by balding, and women enter menopause.
- In the 60–64 age cohort, osteoarthritis rises to 53%. Only 20% however report disabling osteoarthritis at this age.
- In the 70–79 age range, partial hearing loss affecting communication rises to 65%, predominantly among low-income males.
- By age 80, more than half of all Americans either have a cataract or have had cataract surgery.
- Over the age of 85, thirst perception decreases, such that 41% of the elderly drink insufficiently. Frailty, defined as loss of muscle mass and mobility, affects 25% of those over 85.
Dementia becomes more common with age. About 3% of people between the ages of 65–74 have dementia, 19% between 75 and 84 and nearly half of those over 85 years of age. The spectrum includes mild cognitive impairment and the neurodegenerative diseases of Alzheimer's disease, cerebrovascular disease, Parkinson's disease and Lou Gehrig's disease. Furthermore, many types of memory decline with ageing, but not semantic memory or general knowledge such as vocabulary definitions, which typically increases or remains steady until late adulthood (see Ageing brain). Intelligence may decline with age, though the rate may vary depending on the type and may in fact remain steady throughout most of the lifespan, dropping suddenly only as people near the end of their lives. Individual variations in rate of cognitive decline may therefore be explained in terms of people having different lengths of life. There are changes to the brain: after 20 years of age there is a 10% reduction each decade in the total length of the brain's myelinated axons.
Age can result in visual impairment, whereby non-verbal communication is reduced, which can lead to isolation and possible depression. Macular degeneration causes vision loss and increases with age, affecting nearly 12% of those above the age of 80. This degeneration is caused by systemic changes in the circulation of waste products and by growth of abnormal vessels around the retina.
A distinction can be made between "proximal ageing" (age-based effects that come about because of factors in the recent past) and "distal ageing" (age-based differences that can be traced back to a cause early in person's life, such as childhood poliomyelitis).
Ageing is among the greatest known risk factors for most human diseases. Of the roughly 150,000 people who die each day across the globe, about two thirds—100,000 per day—die from age-related causes. In industrialised nations, the proportion is higher, reaching 90%.
Biological basis of ageing
At present, the biological basis of ageing is unknown, even in relatively simple and short-lived organisms. Less still is known about mammalian ageing, in part due to the much longer lives in even small mammals such as the mouse (around 3 years). A primary model organism for studying ageing is the nematode C. elegans, thanks to its short lifespan of 2–3 weeks, the ability to easily perform genetic manipulations or suppress gene activity with RNA interference, and other factors. Most known mutations and RNA interference targets that extend lifespan were first discovered in C. elegans.
Factors that are proposed to influence biological ageing fall into two main categories, programmed and damage-related. Programmed factors follow a biological timetable, perhaps a continuation of the one that regulates childhood growth and development. This regulation would depend on changes in gene expression that affect the systems responsible for maintenance, repair and defence responses. Damage-related factors include internal and environmental assaults to living organisms that induce cumulative damage at various levels.
There are three main metabolic pathways which can influence the rate of ageing:
- the FOXO3/Sirtuin pathway, probably responsive to caloric restriction
- the Growth hormone/Insulin-like growth factor 1 signalling pathway
- the activity levels of the electron transport chain in mitochondria and (in plants) in chloroplasts.
It is likely that most of these pathways affect ageing separately, because targeting them simultaneously leads to additive increases in lifespan.
The rate of ageing varies substantially across different species, and this, to a large extent, is genetically based. For example, numerous perennial plants ranging from strawberries and potatoes to willow trees typically produce clones of themselves by vegetative reproduction and are thus potentially immortal, while annual plants such as wheat and watermelons die each year and reproduce by sexual reproduction. In 2008 it was discovered that inactivation of only two genes in the annual plant Arabidopsis thaliana leads to its conversion into a potentially immortal perennial plant.
Clonal immortality apart, there are certain species whose individual lifespans stand out among Earth's life-forms, including the bristlecone pine at 5062 years (however Hayflick states that the bristlecone pine has no cells older than 30 years), invertebrates like the hard clam (known as quahog in New England) at 508 years, the Greenland shark at 400 years, fish like the sturgeon and the rockfish, and the sea anemone and lobster. Such organisms are sometimes said to exhibit negligible senescence. The genetic aspect has also been demonstrated in studies of human centenarians.
In laboratory settings, researchers have demonstrated that selected alterations in specific genes can extend lifespan quite substantially in yeast and roundworms, less so in fruit flies and less again in mice. Some of the targeted genes have homologues across species and in some cases have been associated with human longevity.
- Telomeres: In humans and other animals, cellular senescence has been attributed to the shortening of telomeres at each cell division; when telomeres become too short, the cells senesce and die or cease multiplying. The length of telomeres is therefore the "molecular clock", predicted by Hayflick. However, telomere length in wild mouse strains is unrelated to lifespan, and mice lacking the telomerase enzyme do not have a dramatically reduced lifespan. Laboratory mice's telomeres are many times longer than human ones. Another caveat is that a study following nearly 1000 humans for ten years showed that while some humans do shorten their telomeres over time, a third of the participants did not.
- A variation in the gene FOXO3A has a positive effect on the life expectancy of humans, and is found much more often in people living to 100 and beyond – moreover, this appears to be true worldwide. FOXO3A acts on the sirtuin family of genes which also have a significant effect on lifespan in yeast and in nematodes. Sirtuin in turn inhibits mTOR.
- Caloric restriction leads to longer lifespans in various species, an effect that is unclear, but probably mediated by the nutrient-sensing function of the mTOR pathway.
- mTOR, a protein that inhibits autophagy, has been linked to ageing through the insulin signalling pathway. mTOR functions through nutrient and growth cues leading scientists to believe that dietary restriction and mTOR are related in terms of longevity. When organisms restrict their diet, mTOR activity is reduced, which allows an increased level of autophagy. This recycles old or damaged cell parts, which increases longevity and decreases the chances of being obese. This is thought to prevent spikes of glucose concentration in the blood, leading to reduced insulin signalling. This has been linked to less mTOR activation as well. Therefore, longevity has been connected to caloric restriction and insulin sensitivity inhibiting mTOR, which in turns allows autophagy to occur more frequently. It may be that mTOR inhibition and autophagy reduce the effects of reactive oxygen species on the body, which damage DNA and other organic material, so longevity would be increased.
- A decreased Growth hormone/Insulin-like Growth Factor 1 signalling pathway has been associated with increased life span in various organisms including fruit flies, nematodes and mice. The precise mechanism by which decreased GH/IGF-1 signalling increases longevity is unknown, but various mouse strains with decreased GH and/or IGF-1 induced signalling share a similar phenotype which includes increased insulin sensitivity, enhanced stress resistance and protection from carcinogenesis. The studied mouse strains with decreased GH signalling showed between 20% and 68% increased longevity, and mouse strains with decreased IGF-1 induced signalling revealed a 19 to 33% increase in life span when compared to control mice.
- DNA methylation: The strong effect of age on DNA methylation levels has been known since the late 1960s. Horvath hypothesised that DNA methylation age measures the cumulative effect of an epigenetic maintenance system but details are unknown. The fact that DNA methylation age of blood predicts all-cause mortality in later life suggests that it relates to a process that causes ageing.
- Over-expression of the Ras2 gene increases lifespan in yeast by 30%. A yeast mutant lacking the genes sch9 and ras2 has recently been shown to have a tenfold increase in lifespan under conditions of calorie restriction and is the largest increase achieved in any organism.
- Evolutionary theories of ageing: Many have argued that life span, like other phenotypes, is selected. Traits that benefit early survival and reproduction will be selected for even if they contribute to an earlier death. Such a genetic effect is called the antagonistic pleiotropy effect when referring to a gene (pleiotropy signifying the gene has a double function – enabling reproduction at a young age but costing the organism life expectancy in old age) and is called the disposable soma effect when referring to an entire genetic programme (the organism diverting limited resources from maintenance to reproduction). Some evidence is provided by oxygen-deprived bacterial cultures. This would explain why the autosomal dominant disease, Huntington's disease, can persist even though it is inexorably lethal. Also, it has been suggested that some of the genetic variants that increase fertility in the young increase cancer risk in the old. Such variants occur in genes p53 and BRCA1. The biological mechanisms which regulate lifespan evolved several hundred million years ago.
- Reproductive-cell cycle theory: The idea that ageing is regulated by reproductive hormones that act in an antagonistic pleiotropic manner via cell cycle signalling, promoting growth and development early in life to achieve reproduction, but becoming dysregulated later in life, driving senescence (dyosis) in a futile attempt to maintain reproductive ability. The endocrine dyscrasia that follows the loss of follicles with menopause, and the loss of Leydig and Sertoli cells during andropause, drive aberrant cell cycle signalling that leads to cell death and dysfunction, tissue dysfunction (disease) and ultimately death. Moreover, the hormones that regulate reproduction also regulate cellular metabolism, explaining the increases in fat deposition during pregnancy through to the deposition of centralised adiposity with the dysregulation of the HPG axis following menopause and during andropause (Atwood and Bowen, 2006). This theory, which introduced a new definition of ageing, has facilitated the conceptualisation of why and how ageing occurs at the evolutionary, physiological and molecular levels.
- Autoimmunity: The idea that ageing results from an increase in autoantibodies that attack the body's tissues. A number of diseases associated with ageing, such as atrophic gastritis and Hashimoto's thyroiditis, are probably autoimmune in this way. However, while inflammation is very much evident in old mammals, even completely immunodeficient mice raised in pathogen-free laboratory conditions still experience senescence.
- The cellular balance between energy generation and consumption (energy homeostasis) requires tight regulation during ageing. In 2011, it was demonstrated that acetylation levels of AMP-activated protein kinase change with age in yeast and that preventing this change slows yeast ageing.
- DNA damage theory of ageing: Genetic damage (aberrant structural alterations of the DNA), mutations (changes in the DNA sequence), and epimutations (methylation of gene promoter regions or alterations of the DNA scaffolding which regulate gene expression), cause abnormal gene expression and can lead to diseases such as cancer. Lifelong studies of mice suggest that most mutations happen during embryonic and childhood development, when cells divide often, as each cell division is a chance for errors in DNA replication. Known causes of cancer were summarised in 1981 by Doll and Peto, including tobacco (30%), alcohol (3%), diet (35%) and other specific factors that add up to about 70% to 90% of cancers. More recent estimates in 2015 agree with those of Doll and Peto. DNA damage causes the cells to stop dividing or induces apoptosis, often affecting stem cell pools and hence hindering regeneration. DNA damage is thought to be the common basis of both cancer and ageing. However, it has been argued that intrinsic causes of DNA damage are the most important drivers of ageing.
- Genetic instability: In heart muscle cells, dogs annually lose approximately 3.3% of the DNA in their heart muscle cells while humans lose approximately 0.6% of their heart muscle DNA each year. These numbers are close to the ratio of the maximum longevities of the two species (120 years vs. 20 years, a 6/1 ratio). The comparative percentage is also similar between the dog and human for yearly DNA loss in the brain and lymphocytes. As stated by lead author, Bernard L. Strehler, "... genetic damage (particularly gene loss) is almost certainly (or probably the) central cause of ageing."
- Accumulation of waste: A buildup of waste products in cells presumably interferes with metabolism. For example, a waste product called lipofuscin is formed by a complex reaction in cells that binds fat to proteins. This waste accumulates in the cells as small granules, which increase in size as a person ages.
- Wear-and-tear theory: The very general idea that changes associated with ageing are the result of chance damage that accumulates over time.
- Accumulation of errors: The idea that ageing results from chance events that escape proof reading mechanisms, which gradually damages the genetic code.
- Cross-linkage: The idea that ageing results from accumulation of cross-linked compounds that interfere with normal cell function.
- Free-radical theory: Damage by free radicals, or more generally reactive oxygen species or oxidative stress, create damage that may gives rise to the symptoms we recognise as ageing. Michael Ristow's group has provided evidence that the effect of calorie restriction may be due to increased formation of free radicals within the mitochondria, causing a secondary induction of increased antioxidant defence capacity.
- DNA oxidation and caloric restriction: Caloric restriction reduces 8-OH-dG DNA damage in organs of ageing rats and mice. Thus, reduction of oxidative DNA damage is associated with a slower rate of ageing and increased lifespan.
Management and reversal
Several drugs and food supplements have been shown to retard or reverse the biological effects of ageing in animal models, but none has yet been proven to do so in humans.
Caloric restriction and exercise are two ways to activate autophagy and inhibit mTOR which can help resolve common age-related health problems.
Caloric restriction substantially affects lifespan in many animals, including the ability to delay or prevent many age-related diseases. Typically, this involves caloric intake of 60–70% of what an ad libitum animal would consume, while still maintaining proper nutrient intake. In rodents, this has been shown to increase lifespan by up to 50%; similar effects occur for yeast and Drosophila. No lifespan data exists for humans on a calorie-restricted diet, but several reports support protection from age-related diseases. Two major ongoing studies on rhesus monkeys initially revealed disparate results; while one study, by the University of Wisconsin, showed that caloric restriction does extend lifespan, the second study, by the National Institute on Ageing (NIA), found no effects of caloric restriction on longevity. Both studies nevertheless showed improvement in a number of health parameters. Notwithstanding the similarly low calorie intake, the diet composition differed between the two studies (notably a high sucrose content in the Wisconsin study), and the monkeys have different origins (India, China), initially suggesting that genetics and dietary composition, not merely a decrease in calories, are factors in longevity. However, in a comparative analysis in 2014, the Wisconsin researchers found that the allegedly non-starved NIA control monkeys in fact are moderately underweight when compared with other monkey populations, and argued this was due to the NIA's apportioned feeding protocol in contrast to Wisconsin's truly unrestricted ad libitum feeding protocol.  They conclude that moderate calorie restriction rather than extreme calorie restriction is sufficient to produce the observed health and longevity benefits in the studied rhesus monkeys.
However, in his book How and Why We Age, Hayflick says that caloric restriction may not be effective in humans, citing data from the Baltimore Longitudinal Study of Aging which shows that being thin does not favour longevity.[need quotation to verify]
Alternatively, the benefits of dietary restriction can also be found by changing the macro nutrient profile to reduce protein intake without any changes to calorie level, resulting in similar increases in longevity. Dietary protein restriction not only inhibits mTOR activity but also IGF-1, two mechanisms implicated in ageing. Specifically, reducing leucine intake is sufficient to inhibit mTOR activity, achievable through reducing animal food consumption.
Rapamycin was first shown to extend lifespan in eukaryotes in 2006 by Powers et al. who showed a dose-responsive effect of rapamycin on lifespan extension in yeast cells. In a 2009 study, the lifespans of mice fed rapamycin were increased between 28 and 38% from the beginning of treatment, or 9 to 14% in total increased maximum lifespan. Of particular note, the treatment began in mice aged 20 months, the equivalent of 60 human years. Rapamycin has subsequently been shown to extend mouse lifespan in several separate experiments, and is now being tested for this purpose in nonhuman primates (the marmoset monkey).
Cancer geneticist Ronald A. DePinho and his colleagues published research in mice where telomerase activity was first genetically removed. Then, after the mice had prematurely aged, they restored telomerase activity by reactivating the telomerase gene. As a result, the mice were rejuvenated: Shrivelled testes grew back to normal and the animals regained their fertility. Other organs, such as the spleen, liver, intestines and brain, recuperated from their degenerated state. "[The finding] offers the possibility that normal human ageing could be slowed by reawakening the enzyme in cells where it has stopped working" says Ronald DePinho. However, activating telomerase in humans could potentially encourage the growth of tumours.
Most known genetic interventions in C. elegans increase lifespan by 1.5 to 2.5-fold. As of 2009[update], the record for lifespan extension in C. elegans is a single-gene mutation which increases adult survival by tenfold. The strong conservation of some of the mechanisms of ageing discovered in model organisms imply that they may be useful in the enhancement of human survival. However, the benefits may not be proportional; longevity gains are typically greater in C. elegans than fruit flies, and greater in fruit flies than in mammals. One explanation for this is that mammals, being much longer-lived, already have many traits which promote lifespan.
Research projects and prizes
The US National Institute on Aging currently funds an intervention testing programme, whereby investigators nominate compounds (based on specific molecular ageing theories) to have evaluated with respect to their effects on lifespan and age-related biomarkers in outbred mice. Previous age-related testing in mammals has proved largely irreproducible, because of small numbers of animals and lax mouse husbandry conditions. The intervention testing programme aims to address this by conducting parallel experiments at three internationally recognised mouse ageing-centres, the Barshop Institute at UTHSCSA, the University of Michigan at Ann Arbor and the Jackson Laboratory.
Several companies and organisations, such as Google Calico, Human Longevity, Craig Venter, Gero, SENS Research Foundation, and Science for Life Extension in Russia, declared stopping or delaying ageing as their goal.
Prizes for extending lifespan and slowing ageing in mammals exist. The Methuselah Foundation offers the Mprize. Recently, the $1 Million Palo Alto Longevity Prize was launched. It is a research incentive prize to encourage teams from all over the world to compete in an all-out effort to "hack the code" that regulates our health and lifespan. It was founded by Joon Yun.
Society and culture
Different cultures express age in different ways. The age of an adult human is commonly measured in whole years since the day of birth. Arbitrary divisions set to mark periods of life may include: juvenile (via infancy, childhood, preadolescence, adolescence), early adulthood, middle adulthood, and late adulthood. More casual terms may include "teenagers," "tweens," "twentysomething", "thirtysomething", etc. as well as "vicenarian", "tricenarian", "quadragenarian", etc.
Most legal systems define a specific age for when an individual is allowed or obliged to do particular activities. These age specifications include voting age, drinking age, age of consent, age of majority, age of criminal responsibility, marriageable age, age of candidacy, and mandatory retirement age. Admission to a movie for instance, may depend on age according to a motion picture rating system. A bus fare might be discounted for the young or old. Each nation, government and non-governmental organisation has different ways of classifying age. In other words, chronological ageing may be distinguished from "social ageing" (cultural age-expectations of how people should act as they grow older) and "biological ageing" (an organism's physical state as it ages).
In a UNFPA report about ageing in the 21st century, it highlighted the need to "Develop a new rights-based culture of ageing and a change of mindset and societal attitudes towards ageing and older persons, from welfare recipients to active, contributing members of society." UNFPA said that this "requires, among others, working towards the development of international human rights instruments and their translation into national laws and regulations and affirmative measures that challenge age discrimination and recognise older people as autonomous subjects." Older persons make vast contributions to society including caregiving and volunteering. For example, "A study of Bolivian migrants who [had] moved to Spain found that 69% left their children at home, usually with grandparents. In rural China, grandparents care for 38% of children aged under five whose parents have gone to work in cities."
Population ageing is the increase in the number and proportion of older people in society. Population ageing has three possible causes: migration, longer life expectancy (decreased death rate) and decreased birth rate. Ageing has a significant impact on society. Young people tend to have fewer legal privileges (if they are below the age of majority), they are more likely to push for political and social change, to develop and adopt new technologies, and to need education. Older people have different requirements from society and government, and frequently have differing values as well, such as for property and pension rights.
In the 21st century, one of the most significant population trends is ageing. Currently, over 11% of the world's current population are people aged 60 and older and the United Nations Population Fund (UNFPA) estimates that by 2050 that number will rise to approximately 22%. Ageing has occurred due to development which has enabled better nutrition, sanitation, health care, education and economic well-being. Consequently, fertility rates have continued to decline and life expectancy have risen. Life expectancy at birth is over 80 now in 33 countries. Ageing is a "global phenomenon," that is occurring fastest in developing countries, including those with large youth populations, and poses social and economic challenges to the work which can be overcome with "the right set of policies to equip individuals, families and societies to address these challenges and to reap its benefits."
As life expectancy rises and birth rates decline in developed countries, the median age itself rises accordingly. According to the United Nations, this process is taking place in nearly every country in the world. A rising median age can have significant social and economic implications, as the workforce gets progressively older and the number of old workers and retirees grows relative to the number of young workers. Older people generally incur more health-related costs than do younger people in the workplace and can also cost more in worker's compensation and pension liabilities. In most developed countries an older workforce is somewhat inevitable. In the United States for instance, the Bureau of Labor Statistics estimates that one in four American workers will be 55 or older by 2020.
Among the most urgent concerns of older persons worldwide is income security. This poses challenges for governments with ageing populations to ensure investments in pension systems continues in order to provide economic independence and reduce poverty in old age. These challenges vary for developing and developed countries. UNFPA stated that, "Sustainability of these systems is of particular concern, particularly in developed countries, while social protection and old-age pension coverage remain a challenge for developing countries, where a large proportion of the labour force is found in the informal sector."
The global economic crisis has increased financial pressure to ensure economic security and access to health care in old age. In order to elevate this pressure "social protection floors must be implemented in order to guarantee income security and access to essential health and social services for all older persons and provide a safety net that contributes to the postponement of disability and prevention of impoverishment in old age."
It has been argued that population ageing has undermined economic development. Evidence suggests that pensions, while making a difference to the well-being of older persons, also benefit entire families especially in times of crisis when there may be a shortage or loss of employment within households. A study by the Australian Government in 2003 estimated that "women between the ages of 65 and 74 years contribute A$16 billion per year in unpaid caregiving and voluntary work. Similarly, men in the same age group contributed A$10 billion per year."
Due to increasing share of the elderly in the population, health care expenditures will continue to grow relative to the economy in coming decades. This has been considered as a negative phenomenon and effective strategies like labour productivity enhancement should be considered to deal with negative consequences of ageing.
In the field of sociology and mental health, ageing is seen in five different views: ageing as maturity, ageing as decline, ageing as a life-cycle event, ageing as generation, and ageing as survival. Positive correlates with ageing often include economics, employment, marriage, children, education, and sense of control, as well as many others. The social science of ageing includes disengagement theory, activity theory, selectivity theory, and continuity theory. Retirement, a common transition faced by the elderly, may have both positive and negative consequences. As cyborgs currently are on the rise some theorists argue there is a need to develop new definitions of ageing and for instance a bio-techno-social definition of ageing has been suggested.
Health care demand
With age inevitable biological changes occur that increase the risk of illness and disability. UNFPA states that,
"A life-cycle approach to health care – one that starts early, continues through the reproductive years and lasts into old age – is essential for the physical and emotional well-being of older persons, and, indeed, all people. Public policies and programmes should additionally address the needs of older impoverished people who cannot afford health care."
Many societies in Western Europe and Japan have ageing populations. While the effects on society are complex, there is a concern about the impact on health care demand. The large number of suggestions in the literature for specific interventions to cope with the expected increase in demand for long-term care in ageing societies can be organised under four headings: improve system performance; redesign service delivery; support informal caregivers; and shift demographic parameters.
However, the annual growth in national health spending is not mainly due to increasing demand from ageing populations, but rather has been driven by rising incomes, costly new medical technology, a shortage of health care workers and informational asymmetries between providers and patients. A number of health problems become more prevalent as people get older. These include mental health problems as well as physical health problems, especially dementia.
It has been estimated that population ageing only explains 0.2 percentage points of the annual growth rate in medical spending of 4.3% since 1970. In addition, certain reforms to the Medicare system in the United States decreased elderly spending on home health care by 12.5% per year between 1996 and 2000.
Self-perception of ageing
Positive self-perception of health has been correlated with higher well-being and reduced mortality in the elderly. Various reasons have been proposed for this association; people who are objectively healthy may naturally rate their health better than that of their ill counterparts, though this link has been observed even in studies which have controlled for socioeconomic status, psychological functioning and health status. This finding is generally stronger for men than women, though this relationship is not universal across all studies and may only be true in some circumstances.
As people age, subjective health remains relatively stable, even though objective health worsens. In fact, perceived health improves with age when objective health is controlled in the equation. This phenomenon is known as the "paradox of ageing." This may be a result of social comparison; for instance, the older people get, the more they may consider themselves in better health than their same-aged peers. Elderly people often associate their functional and physical decline with the normal ageing process.
The concept of successful ageing can be traced back to the 1950s and was popularised in the 1980s. Traditional definitions of successful ageing have emphasised absence of physical and cognitive disabilities. In their 1987 article, Rowe and Kahn characterised successful ageing as involving three components: a) freedom from disease and disability, b) high cognitive and physical functioning, and c) social and productive engagement.
- Ageing brain
- Ageing movement control
- Ageing of Europe
- Anti-ageing movement
- Biodemography of human longevity
- Biological immortality
- Biomarkers of ageing
- Clinical Geropsychology
- Epigenetic clock
- Genetics of ageing
- List of life extension-related topics
- Old age
- Population ageing
- Stem cell theory of ageing
- Transgenerational design
- Bowen, Richard L.; Atwood, Craig S. (2004). "Living and Dying for Sex". Gerontology. 50 (5): 265–90. doi:10.1159/000079125. PMID 15331856.
- Dillin A, Gottschling DE, Nyström T (2014). "The good and the bad of being connected: the integrons of aging". Curr Opin Cell Biol. 26: 107–12. doi:10.1016/j.ceb.2013.12.003. PMC . PMID 24529252.
- Forster P, Hohoff C, Dunkelmann B, Schürenkamp M, Pfeiffer H, Neuhuber F, Brinkmann B (2015). "Elevated germline mutation rate in teenage fathers". Proc R Soc B. 282 (1803): 1–6. doi:10.1098/rspb.2014.2898. PMC . PMID 25694621.
- Wakayama S, Kohda T, Obokata H, Tokoro M, Li C, Terashita Y, Mizutani E, Nguyen VT, Kishigami S, Ishino F, Wakayama T (2013). "Successful serial recloning in the mouse over multiple generations". Cell Stem Cell. 12 (3): 293–297. doi:10.1016/j.stem.2013.01.005. PMID 23472871.
- Salthouse, Timothy A. (2009). "When does age-related cognitive decline begin?". Neurobiology of Aging. 30 (4): 507–14. doi:10.1016/j.neurobiolaging.2008.09.023. PMC . PMID 19231028.
- Desjardins, Richard; Warnke, Arne Jonas (2012). "Ageing and Skills". OECD Education Working Papers. doi:10.1787/5k9csvw87ckh-en.
- Scientific American, "Why does hair turn gray?"
- Thomas, Elaine; Peat, George; Croft, Peter (2014). "Defining and mapping the person with osteoarthritis for population studies and public health". Rheumatology (Oxford). 53 (2): 338–345. doi:10.1093/rheumatology/ket346. PMC . PMID 24173433.
- Feder, K.; Michaud, D.; Ramage-Morin, P.; McNamee, J.; Beauregard, Y. (2015). "Prevalence of hearing loss among Canadians aged 20 to 79: Audiometric results from the 2012/2013 Canadian Health Measures Survey". Health Reports. 26 (7): 18–25. PMID 26177043.
- "Facts About Cataract". September 2015. Retrieved 14 August 2016.
- cf. Table 6 in: Harold A. Kahn, Howard M. Leibowitz, James P. Ganley, Mohandas M. Kini, Theodore Colton, Rita S. Nickerson, Thomas R. Dawber (1977) The Framingham Eye Study I. Outline And Major Prevalence Findings. American Journal of Epidemiology Vol 106, No 1, pp17-32
- Volkert D, Kreuel K, Stehle P (2005). "Fluid intake of community-living, independent elderly in Germany-a nationwide, representative study". J Nutr Health Aging. 9 (5): 305–9. PMID 16222395.
- Fried, LP; Tangen, CM; Walston, J; Newman, AB; Hirsch, C; Gottdiener, J; Seeman, T; Tracy, R; Kop, WJ; Burke, G; McBurnie, MA (Mar 2001). "Frailty in older adults: evidence for a phenotype". The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 56 (3): M146–56. doi:10.1093/gerona/56.3.m146. PMID 11253156.
- Percentage derived from Table 2 in Fried et al. 2001
- Larson, EB; Yaffe, K; Langa, KM (12 December 2013). "New insights into the dementia epidemic.". The New England Journal of Medicine. 369 (24): 2275–7. doi:10.1056/nejmp1311405. PMID 24283198.
- Umphred, Darcy (2012). Neurological rehabilitation (6th ed.). St. Louis, Mo.: Elsevier Mosby. p. 838. ISBN 978-0-323-07586-2.
- Schaie, K. Warner (2005). Developmental Influences on Adult Intelligence. doi:10.1093/acprof:oso/9780195156737.001.0001. ISBN 978-0-19-515673-7.[page needed]
- Stuart-Hamilton, Ian (2006). The Psychology of Ageing: An Introduction. London: Jessica Kingsley Publishers. ISBN 1-84310-426-1.
- Marner, Lisbeth; Nyengaard, Jens R.; Tang, Yong; Pakkenberg, Bente (2003). "Marked loss of myelinated nerve fibers in the human brain with age". The Journal of Comparative Neurology. 462 (2): 144–52. doi:10.1002/cne.10714. PMID 12794739.
- Worrall, L.,& Hickson, L. M. (2003). "Theoretical foundations of communication disability in aging", pp. 32–33 in Linda E. Worrall & Louise M. Hickson(Eds.). Communication disability in aging: from prevention to intervention. Clifton Park, NY: Delmar Learning
- Mehta, S (September 2015). "Age-Related Macular Degeneration.". Primary care. 42 (3): 377–91. doi:10.1016/j.pop.2015.05.009. PMID 26319344.
- Nussbaum, J. F., Thompson, T. L., & Robinson, J. D. (1989). "Barriers to conversation", pp. 234–253 in Jon F. Nussbaum, Teresa Thompson, James D. Robinson (Eds.). Communication and aging. New York: Harper & Row
- De Grey, Aubrey D.N.J (2007). "Life Span Extension Research and Public Debate: Societal Considerations". Studies in Ethics, Law, and Technology. 1. doi:10.2202/1941-6008.1011.
- Lopez, Alan D; Mathers, Colin D; Ezzati, Majid; Jamison, Dean T; Murray, Christopher JL (2006). "Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data". The Lancet. 367 (9524): 1747–57. doi:10.1016/S0140-6736(06)68770-9. PMID 16731270.
- Brunet Lab: Molecular Mechanisms of Longevity and Age Related Diseases. Stanford.edu. Retrieved on 11 April 2012.
- Deepti S. Wilkinson; Rebecca C. Taylor; Andrew Dillin (2012). "Analysis of Aging in Caenorhabditis elegans". In Joel H. Rothman; Andrew Singson. Caenorhabditis Elegans: Cell Biology and Physiology. Academic Press. pp. 353–381. ISBN 978-0-12-394620-1.
- Shmookler Reis RJ, Bharill P, Tazearslan C, Ayyadevara S (2009). "Extreme-longevity mutations orchestrate silencing of multiple signaling pathways". Biochim Biophys Acta. 1790 (10): 1075–83. doi:10.1016/j.bbagen.2009.05.011. PMC . PMID 19465083.
- "Mitochondrial Theory of Aging and Other Aging Theories". 1Vigor. Retrieved 4 October 2013.
- Jin, Kunlin (2010). "Modern Biological Theories of Aging.". Aging Dis. 1 (2): 72–74. PMC . PMID 21132086.
- Guarente, Leonard P.; Partridge, Linda; Wallace, Douglas C. (2008). Molecular Biology of Aging. New York: Cold Spring Harbor. pp. 347–362. ISBN 978-0-87969-824-9.
- Taylor RC, Dillin A (2011). "Aging as an event of proteostasis collapse.". Cold Spring Harb Perspect Biol. 3 (5): a004440. doi:10.1101/cshperspect.a004440. PMC . PMID 21441594.
- Melzer, S; Lens, F; Gennen, J; Vanneste, S; Rohde, A; Beeckman, T (2008). "Flowering-time genes modulate meristem determinacy and growth form in Arabidopsis thaliana". Nature Genetics. 40 (12): 1489–92. doi:10.1038/ng.253. PMID 18997783.
- "Oldlist". Rocky Mountain Tree Ring Research. Retrieved 2016-08-12.
- Danuta Sosnowska, Chris Richardson, William E. Sonntag, Anna Csiszar, Zoltan Ungvari, Iain Ridgway (2014). "A Heart That Beats for 500 Years: Age-Related Changes in Cardiac Proteasome Activity, Oxidative Protein Damage and Expression of Heat Shock Proteins, Inflammatory Factors, and Mitochondrial Complexes in Arctica islandica, the Longest-Living Noncolonial Animal". J Gerontol a Biol Sci Med Sci. 69 (12): 1448–61. doi:10.1093/gerona/glt201. PMC . PMID 24347613.
- Julius Nielsen, Rasmus B. Hedeholm, Jan Heinemeier, Peter G. Bushnell, Jørgen S. Christiansen, Jesper Olsen, Christopher Bronk Ramsey, Richard W. Brill, Malene Simon, Kirstine F. Steffensen, John F. Steffensen (2016). "Eye lens radiocarbon reveals centuries of longevity in the Greenland shark (Somniosus microcephalus).". Science. 353 (6300): 702–704. doi:10.1126/science.aaf1703.
- Timiras, Paola S. (2003) Physiological Basis of Ageing and Geriatrics. Informa Health Care. ISBN 0-8493-0948-4. p. 26.
- Silverman, Jacob. "Is there a 400 pound lobster out there?". howstuffworks.
- Wallace, David Foster (2005). Consider the Lobster and Other Essays. Little, Brown & Company. ISBN 0-316-15611-6.[page needed]
- Guerin, J (2004). "Emerging area of aging research: long-lived animals with "negligible senescence"". Ann N Y Acad Sci. 1019: 518–20. doi:10.1196/annals.1297.096. PMID 15247078.
- Bartke A (2011). "Single-gene mutations and healthy ageing in mammals.". Philos Trans R Soc Lond B Biol Sci. 366 (1561): 28–34. doi:10.1098/rstb.2010.0281. PMC . PMID 21115527.
- Stibich, Mark (19 April 2009) Telomere Shortening – The Secret to Aging?. About.com
- m. Mikhelson, Victor; Gamaley, Irina (2013). "Telomere Shortening is a Sole Mechanism of Aging in Mammals". Current Aging Science. 5 (3): 203–8. doi:10.2174/1874609811205030006. PMID 23387887.
- Hayflick, L. (1987) Origins of longevity. In Warner, H.R., Butler, R.N., Sprott, R.L. and Schneider, E.L. (eds), Modern Biological Theories of Aging. Raven Press, New York, pp. 21–34. ISBN 0-88167-310-2
- Bernstein C, Bernstein H. (1991) Aging, Sex, and DNA Repair. Academic Press, San Diego. ISBN 0-12-092860-4. pp. 314, 320 and 326
- Hemann, M. T.; Greider, CW (2000). "Wild-derived inbred mouse strains have short telomeres". Nucleic Acids Research. 28 (22): 4474–8. doi:10.1093/nar/28.22.4474. PMC . PMID 11071935.
- Blasco, María A; Lee, Han-Woong; Hande, M.Prakash; Samper, Enrique; Lansdorp, Peter M; Depinho, Ronald A; Greider, Carol W (1997). "Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA". Cell. 91 (1): 25–34. doi:10.1016/S0092-8674(01)80006-4. PMID 9335332.
- Kipling, David; Cooke, Howard J. (1990). "Hypervariable ultra-long telomeres in mice". Nature. 347 (6291): 400–2. Bibcode:1990Natur.347..400K. doi:10.1038/347400a0. PMID 2170845.
- Nordfjäll K, Svenson U, Norrback K-F, Adolfsson R, Lenner P, Roos G. The individual blood cell telomere attrition rate is telomere length dependent. PLoS Genetics, February 13, 2009 DOI: 10.1371/journal.pgen.1000375[/sun]
- Willcox B. J. (2008). "FOXO3A genotype is strongly associated with human longevity". PNAS. 105 (37): 13987–13992. doi:10.1073/pnas.0801030105. PMC . PMID 18765803.
- Flachsbart F, Caliebe A, Kleindorp R, Blanché H, von Eller-Eberstein H, Nikolaus S, Schreiber S, Nebel A. (2009). "Association of FOXO3A variation with human longevity confirmed in German centenarians". PNAS. 106 (8): 2700–5. doi:10.1073/pnas.0809594106. PMC . PMID 19196970.
- H. S. Ghosh et al.: SIRT1 negatively regulates the mammalian target of rapamycin. In: PLOS ONE. 5, 2010, e9199. PMID 20169165 PMC 2821410.
- Fontana L, Partridge L, Longo VD (2010). "Extending healthy life span—from yeast to humans". Science. 328 (5976): 321–6. Bibcode:2010Sci...328..321F. doi:10.1126/science.1172539. PMC . PMID 20395504.
- Johnson, Simon C.; Rabinovitch, Peter S.; Kaeberlein, Matt (2013). "MTOR is a key modulator of ageing and age-related disease". Nature. 493 (7432): 338–45. Bibcode:2013Natur.493..338J. doi:10.1038/nature11861. PMC . PMID 23325216.
- Junnila, RK; List, EO; Berryman, DE; Murrey, JW; Kopchick, JJ (2013). "The GH/IGF-1 axis in ageing and longevity". Nat Rev Endocrinol. 9 (6): 366–76. doi:10.1038/nrendo.2013.67. PMC . PMID 23591370.
- Berdyshev, G; Korotaev, G; Boiarskikh, G; Vaniushin, B (1967). "Nucleotide composition of DNA and RNA from somatic tissues of humpback and its changes during spawning". Biokhimiia. 31: 88–993.
- Marioni, R; Shah, S; McRae, A; Chen, B; Colicino, E; Harris, S; Gibson, J; Henders, A; Redmond, P; Cox, S; Pattie, A; Corley, J; Murphy, L; Martin, N; Montgomery, G; Feinberg, A; Fallin, M; Multhaup, M; Jaffe, A; Joehanes, R; Schwartz, J; Just, A; Lunetta, K; Murabito, JM; Starr, J; Horvath, S; Baccarelli, A; Levy, D; Visscher, P; Wray, N; Deary, I (2015). "DNA methylation age of blood predicts all-cause mortality in later life". Genome Biology. 16 (1): 25. doi:10.1186/s13059-015-0584-6.
- Christiansen, L (2015). "DNA methylation age is associated with mortality in a longitudinal Danish twin study". Aging Cell. 15 (1): 149–154. doi:10.1111/acel.12421. PMC . PMID 26594032.
- Horvath, S (2015). "Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring". Aging (US Albany NY) (Dec).
- J Sun; Kale, SP; Childress, AM; Pinswasdi, C; Jazwinski, SM (15 July 1994). "Divergent roles of RAS1 and RAS2 in yeast longevity". Journal of Biological Chemistry. 269 (28): 18638–45. PMID 8034612.
- Wei M, Fabrizio P, Hu J, Ge H, Cheng C, Li L, Longo VD (2008). "Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9". PLoS Genet. 4 (1): 139–149. doi:10.1371/journal.pgen.0040013. PMC . PMID 18225956.
- "10-Fold Life Span Extension Reported". University of Southern California.
- Williams, George C. (1957). "Pleiotropy, Natural Selection, and the Evolution of Senescence". Evolution. 11 (4): 398–411. doi:10.2307/2406060. JSTOR 2406060.
- Nyström, T. (2003). "The free-radical hypothesis of aging goes prokaryotic". Cellular and Molecular Life Sciences (CMLS). 60 (7): 1333–41. doi:10.1007/s00018-003-2310-X. PMID 12943222.
- Kang, H.-J.; Feng, Z.; Sun, Y.; Atwal, G.; Murphy, M. E.; Rebbeck, T. R.; Rosenwaks, Z.; Levine, A. J.; Hu, W. (2009). "Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans". Proceedings of the National Academy of Sciences. 106 (24): 9761–6. Bibcode:2009PNAS..106.9761K. doi:10.1073/pnas.0904280106. PMC . PMID 19470478.
- Smith, K. R.; Hanson, H. A.; Mineau, G. P.; Buys, S. S. (2011). "Effects of BRCA1 and BRCA2 mutations on female fertility". Proceedings of the Royal Society B: Biological Sciences. 279 (1732): 1389–95. doi:10.1098/rspb.2011.1697. PMC . PMID 21993507.
- Atwood, Craig S.; Bowen, Richard L. (2011). "The reproductive-cell cycle theory of aging: An update". Experimental Gerontology. 46 (2–3): 100–7. doi:10.1016/j.exger.2010.09.007. PMID 20851172.
- Mair W, Steffen KK, Dillin A (2011). "SIP-ing the elixir of youth". Cell. 146 (6): 859–60. doi:10.1016/j.cell.2011.08.026. PMID 21925309.
- L. Robert; J. Labat-Robert; A. M. Robert (2010). "Genetic, epigenetic and posttranslational mechanisms of aging". Biogerontology. 11 (4): 387–399. doi:10.1007/s10522-010-9262-y. PMID 20157779.
- Doll R, Peto R (1981). "The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today". J. Natl. Cancer Inst. 66 (6): 1191–308. doi:10.1093/jnci/66.6.1192 (inactive 2016-08-16). PMID 7017215.
- Blot WJ, Tarone RE (2015). "Doll and Peto's quantitative estimates of cancer risks: holding generally true for 35 years". J. Natl. Cancer Inst. 107 (4): djv044. doi:10.1093/jnci/djv044. PMID 25739419.
- Gensler, Helen L.; Bernstein, Harris (1981). "DNA Damage as the Primary Cause of Aging". The Quarterly Review of Biology. 56 (3): 279–303. doi:10.1086/412317. JSTOR 2826464. PMID 7031747.
- Sinha, Jitendra Kumar; Ghosh, Shampa; Swain, Umakanta; Giridharan, Nappan Veethil; Raghunath, Manchala (2014). "Increased macromolecular damage due to oxidative stress in the neocortex and hippocampus of WNIN/Ob, a novel rat model of premature aging". Neuroscience. 269: 256–64. doi:10.1016/j.neuroscience.2014.03.040. PMID 24709042.
- Freitas, Alex A.; De Magalhães, João Pedro (2011). "A review and appraisal of the DNA damage theory of ageing". Mutation Research/Reviews in Mutation Research. 728 (1–2): 12–22. doi:10.1016/j.mrrev.2011.05.001. PMID 21600302.
- Strehler, Bernard L. (1986). "Genetic instability as the primary cause of human aging". Experimental Gerontology. 21 (4–5): 283–319. doi:10.1016/0531-5565(86)90038-0. PMID 3545872.
- Gavrilov, L. A.; Gavrilova, N. S. (2006), "Reliability Theory of Aging and Longevity", pp. 3–42 in Handbook of the Biology of Aging, ed. Masoro E. J. and Austad S. N, Academic Press, San Diego, CA.
- Jin K (2010). "Modern Biological Theories of Aging.". Aging Dis. 1 (2): 72–74. PMC . PMID 21132086.
- Bjorksten, Johan; Tenhu, Heikki (1990). "The crosslinking theory of aging — Added evidence". Experimental Gerontology. 25 (2): 91–5. doi:10.1016/0531-5565(90)90039-5. PMID 2115005.
- Harman, D. (1981). "The aging process". Proceedings of the National Academy of Sciences. 78 (11): 7124–8. Bibcode:1981PNAS...78.7124H. doi:10.1073/pnas.78.11.7124. PMC . PMID 6947277.
- Schulz, Tim J.; Zarse, Kim; Voigt, Anja; Urban, Nadine; Birringer, Marc; Ristow, Michael (2007). "Glucose Restriction Extends Caenorhabditis elegans Life Span by Inducing Mitochondrial Respiration and Increasing Oxidative Stress". Cell Metabolism. 6 (4): 280–93. doi:10.1016/j.cmet.2007.08.011. PMID 17908557.
- Hamilton ML, Van Remmen H, Drake JA, Yang H, Guo ZM, Kewitt K, Walter CA, Richardson A (2001). "Does oxidative damage to DNA increase with age?". Proc. Natl. Acad. Sci. U.S.A. 98 (18): 10469–74. doi:10.1073/pnas.171202698. PMC . PMID 11517304.
- Wolf FI, Fasanella S, Tedesco B, Cavallini G, Donati A, Bergamini E, Cittadini A (2005). "Peripheral lymphocyte 8-OHdG levels correlate with age-associated increase of tissue oxidative DNA damage in Sprague-Dawley rats. Protective effects of caloric restriction". Exp. Gerontol. 40 (3): 181–8. doi:10.1016/j.exger.2004.11.002. PMID 15763395.
- Guarente L, Picard F (2005). "Calorie restriction—the SIR2 connection". Cell. 120 (4): 473–82. doi:10.1016/j.cell.2005.01.029. PMID 15734680.
- Agarwal B, Baur JA (2011). "Resveratrol and life extension". Ann N Y Acad Sci. 1215 (1): 138–43. Bibcode:2011NYASA1215..138A. doi:10.1111/j.1749-6632.2010.05850.x. PMID 21261652.
- Larson-Meyer DE, et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) 2008;16:1355–1362.
- Heilbronn LK, et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA. 2006;295:1539–1548.
- Colman RJ, Anderson RM, Johnson SC, Kastman EK, et al. (2009). "Caloric restriction delays disease onset and mortality in rhesus monkeys". Science. 325 (5937): 201–4. Bibcode:2009Sci...325..201C. doi:10.1126/science.1173635. PMC . PMID 19590001.
- Mattison, Julie A.; et al. (2012). "Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study". Nature. 489 (7415): 318–321. Bibcode:2012Natur.489..318M. doi:10.1038/nature11432. PMC . PMID 22932268.
- Colman RJ; Beasley TM; Kemnitz JW; Johnson SC; Weindruch R; Anderson RM (Apr 1, 2014). "Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys". Nature Communications. 5: 3557. Bibcode:2014NatCo...5E3557C. doi:10.1038/ncomms4557. PMC . PMID 24691430. Retrieved 30 April 2014.
- "There may be little advantage of moderate CR over modest CR—this would be an extremely important discovery and one that merits further investigation."
- Hayflick, Leonard. (1994). How and why we age. New York: Ballantine Books. p. 261. ISBN 978-0-345-33918-8. OCLC 29908633.
- Nakagawa, Shinichi; Lagisz, Malgorzata; Hector, Katie L.; Spencer, Hamish G. (2012-06-01). "Comparative and meta-analytic insights into life extension via dietary restriction". Aging Cell. 11 (3): 401–409. doi:10.1111/j.1474-9726.2012.00798.x. ISSN 1474-9726. PMID 22268691.
- Simpson, Stephen J.; Raubenheimer, David (2009-10-22). "Macronutrient balance and lifespan". Aging (Albany NY). 1 (10): 875–880. doi:10.18632/aging.100098. ISSN 1945-4589. PMC . PMID 20157561.
- Melnik, Bodo C. (2012-03-15). "Leucine signaling in the pathogenesis of type 2 diabetes and obesity". World Journal of Diabetes. 3 (3): 38–53. doi:10.4239/wjd.v3.i3.38. ISSN 1948-9358. PMC . PMID 22442749.
- Yan, Lijun; Lamb, Richard F. (2012-08-01). "Amino acid sensing and regulation of mTORC1". Seminars in Cell & Developmental Biology. 23 (6): 621–625. doi:10.1016/j.semcdb.2012.02.001. ISSN 1096-3634. PMID 22342805.
- Lam YY, Peterson CM, Ravussin E (2013). "Resveratrol vs. calorie restriction: data from rodents to humans". Exp Gerontol. 48 (10): 1018–24. doi:10.1016/j.exger.2013.04.005. PMID 23624181.
- Pryor, R; Cabreiro, F (1 November 2015). "Repurposing metformin: an old drug with new tricks in its binding pockets.". The Biochemical Journal. 471 (3): 307–22. doi:10.1042/bj20150497. PMID 26475449.
- Powers RW, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S (2006). "Extension of chronological life span in yeast by decreased TOR pathway signaling". Genes Dev. 20 (2): 174–84. doi:10.1101/gad.1381406. PMC . PMID 16418483.
- Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA (2009). "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice". Nature. 460 (7253): 392–5. doi:10.1038/nature08221. PMC . PMID 19587680. Lay summary – The Times (8 July 2009).
- Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R (February 2011). "Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice". J. Gerontol. A Biol. Sci. Med. Sci. 66 (2): 191–201. doi:10.1093/gerona/glq178. PMC . PMID 20974732.
- Ingram DK, Roth GS (March 2011). "Glycolytic inhibition as a strategy for developing calorie restriction mimetics". Experimental Gerontology (review). 46 (2–3): 148–154. doi:10.1016/j.exger.2010.12.001. PMID 21167272.
- Tardif, S; Ross, C; Bergman, P; Fernandez, E; Javors, M; Salmon, A; Spross, J; Strong, R; Richardson, A (19 July 2014). "Testing Efficacy of Administration of the Antiaging Drug Rapamycin in a Nonhuman Primate, the Common Marmoset". J Gerontol A Biol Sci Med Sci. 70: 577–588. doi:10.1093/gerona/glu101. PMID 25038772.
- Callaway, Ewen (2010). "Telomerase reverses ageing process". Nature. doi:10.1038/news.2010.635.
- Blagosklonny, M. V. (2009). "Validation of anti-aging drugs by treating age-related diseases". Aging. 1 (3): 281–8. PMC . PMID 20157517.
- Kogan, Valeria; Molodtcov, Ivan; Menshikov, Leonid I.; Shmookler Reis, Robert J.; Fedichev, Peter (2015). "Stability analysis of a model gene network links aging, stress resistance, and negligible senescence". Scientific Reports. 5.
- "Scientists' Open Letter on Aging". imminst.org.
- Miller, Richard A.; Harrison, David E.; Astle, Clinton M.; Floyd, Robert A.; Flurkey, Kevin; Hensley, Kenneth L.; Javors, Martin A.; Leeuwenburgh, Christiaan; Nelson, James F.; Ongini, Ennio; Nadon, Nancy L.; Warner, Huber R.; Strong, Randy (2007). "An aging Interventions Testing Program: Study design and interim report". Aging Cell. 6 (4): 565–75. doi:10.1111/j.1474-9726.2007.00311.x. PMID 17578509.
- "Ageing". Gero. Retrieved 2015-02-04.
- "Science for Life Extension". Science against aging foundation. Retrieved 2015-02-03.
- "FAQ – Palo Alto Longevity Prize". Palo Alto Longevity Prize. Retrieved 1 October 2014.
- Ashlee Vance (9 September 2014). "Silicon Valley Investor Backs $1 Million Prize to End Death". Bloomberg Businessweek. Retrieved 1 October 2014.
- "$1 Million Longevity Prize Seeks To "Hack The Aging Code"" (Press release). Yahoo! Finance. 9 September 2014. Retrieved 1 October 2014.
- Aaron Kinney (14 September 2014). "Silicon Valley launches another bid to 'hack' aging, cheat death". San Jose Mercury News. Retrieved 1 October 2014.
- Victoria Thorp (23 November 2014). "The Palo Alto Prize: A 'Moonshot' at Increasing Longevity". Palo Alto Pulse. Retrieved 8 December 2014.
- Phillips, Judith, Kristine Ajrouch, and Sarah Hillcoat-Nallétamby (2010) Key Concepts in Social Gerontology. SAGE Publications.ISBN 978-1-4462-0428-3. pp. 12–13.
- "Ageing in the Twenty-First Century". UNFPA. 2012.
- Vincent, John A. (2005). "Understanding generations: Political economy and culture in an ageing society". The British Journal of Sociology. 56 (4): 579–99. doi:10.1111/j.1468-4446.2005.00084.x. PMID 16309437.
- "Population Ageing and Development". UNFPA. 2002.
- "UN Human Development Report 2005" (PDF). United Nations Development Programme. Archived from the original (PDF) on 27 May 2008. Retrieved 7 October 2010.
- Chosewood, L. Casey. "Safer and Healthier at Any Age: Strategies for an Aging Workforce". NIOSH Science Blog. National Institute for Occupational Safety and Health. Retrieved 6 August 2012.
- Basakha M; Yavari K; Sadeghi H; Naseri A. (2015). "Population Aging And Iran's Non-Oil Economic Growth". Payavard Salamat. 9 (2): 131–146.
- Basakha M, Yavari K, Sadeghi H, Naseri A (2014). "Ageing and Macroeconomics; Healthcare cost disease as a threat to Iranian ageing society". Journal of Research in Health Sciences. pp. 152–6.
- Scheid, Teresa L.; Brown, Tony N. (2010). A Handbook for the Study of Mental Health (Second ed.). New York: Cambridge University Press.
- Panek, Paul E.; Hayslip, Bert (1989). Adult development and aging. San Francisco: Harper & Row. ISBN 0-06-045012-6.[page needed]
- Anita Wejbrandt (2014) Defining aging in cyborgs: A bio-techno-social definition of aging, Journal of Aging Studies, Volume 31, Pages 104–109
- Chawla, Mukesh; Dubois, Hans F. W.; Chawla, Richard B. (2006). "The Impact of Aging on Long-Term Care in Europe and Some Potential Policy Responses". International Journal of Health Services. 36 (4): 719–46. doi:10.2190/AUL1-4LAM-4VNB-3YH0. PMID 17175843.
- Reinhardt, U. E. (2003). "Does the Aging of the Population Really Drive the Demand for Health Care?". Health Affairs. 22 (6): 27–39. doi:10.1377/hlthaff.22.6.27. PMID 14649430.
- Meara, E.; White, C.; Cutler, D. M. (2004). "Trends in Medical Spending by Age, 1963–2000". Health Affairs. 23 (4): 176–83. doi:10.1377/hlthaff.23.4.176. PMID 15318578.
- Idler, E. L. (2003). "Discussion: Gender Differences in Self-Rated Health, in Mortality, and in the Relationship Between the Two". The Gerontologist. 43 (3): 372–375. doi:10.1093/geront/43.3.372.
- Deeg, D. J. H.; Bath, P. A. (2003). "Self-Rated Health, Gender, and Mortality in Older Persons: Introduction to a Special Section". The Gerontologist. 43 (3): 369–71. doi:10.1093/geront/43.3.369. PMID 12810900.
- Benyamini, Y.; Blumstein, T.; Lusky, A.; Modan, B. (2003). "Gender Differences in the Self-Rated Health-Mortality Association: Is It Poor Self-Rated Health That Predicts Mortality or Excellent Self-Rated Health That Predicts Survival?". The Gerontologist. 43 (3): 396–405; discussion 372–5. doi:10.1093/geront/43.3.396. PMID 12810904.
- Kunzmann, Ute; Little, Todd D; Smith, Jacqui (2000). "Is age-related stability of subjective well-being a paradox? Cross-sectional and longitudional evidence from the Berlin Aging Study.". Psychology and Aging. 15 (3): 511–526. doi:10.1037/0882-7918.104.22.1681.
- Jylhä, Marja; Guralnik, Jack M; Balfour, Jennifer; Fried, Linda P (2001). "Walking Difficulty, Walking Speed, and Age as Predictors of Self-Rated Health: The Women's Health and Aging Study". Journal of Gerontology. 56A (10): 609. PMID 11584033.
- Heckhausen, Jutta (1999). Developmental Regulation in Adulthood: Age-Normative and Sociostructural Constraints as Adaptive Challenges. Cambridge University Press. ISBN 978-0-521-02713-7.
- Sargent-Cox, Kerry; Anstey, Kaarin; Luszcz, Mary (2008). "Determinants of Self-Rated Health Items With Different Points of Reference". Journal of Aging and Health. 20 (6): 739–761. doi:10.1177/0898264308321035.
- Idler, Ellen L (1993). "Age differences in self-assessments of health: Age changes, cohort difference, or survivorship?". Journal of Gerontology. 48 (6): S289. doi:10.1093/geronj/48.6.s289.
- Williamson, JD; Fried, LP (1996). "Characterization of older adults who attribute functional decrements to "old age"". Journal of the American Geriatrics Society. 44 (12): 1429–1434. doi:10.1111/j.1532-5415.1996.tb04066.x.
- Baltes, Paul B.; Baltes, Margret M. (1990). "Psychological perspectives on successful aging: The model of selective optimization with compensation". In Baltes, Paul B.; Baltes, Margret M. Successful Aging. pp. 1–34. doi:10.1017/CBO9780511665684.003. ISBN 978-0-511-66568-4.
- Rowe, J.; Kahn, R. (1987). "Human aging: Usual and successful". Science. 237 (4811): 143–9. Bibcode:1987Sci...237..143R. doi:10.1126/science.3299702. PMID 3299702.
Find more about
at Wikipedia's sister projects
|Definitions from Wiktionary|
|Media from Commons|
|Quotations from Wikiquote|
|Textbooks from Wikibooks|
|Data from Wikidata|
- Global AgeWatch Statistics on population ageing and life expectancy
- HelpAge International and UNFPA (2012). Ageing in the 21st Century – A Celebration and A Challenge.